First Ebola treatment study begins in Congo outbreak
Researchers in Congo have launched a clinical trial testing two experimental treatments for the Bundibugyo strain of Ebola. The study aims to improve survival rates for an outbreak that has already claimed hundreds of lives.
Why it matters
Finding effective treatments for rare and deadly Ebola strains is critical for global health security and preventing regional humanitarian crises.
Add AP News as your preferred source to see more of our stories on Google. --> Share
Objective reporting on medical research and public health developments.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in